Asensus Surgical Inc (ASXC): Market Cap to Revenue

Symbol and logo of brand TransEnterix (ASXC)

Asensus Surgical, Inc. (ASXC) automates medical staff workflows by replacing assistant functions. Senhance technologies featuring haptic feedback and eye-tracking control enhance surgical precision. The current P/S multiple provided by the GURU.Markets platform demonstrates the proportionality of the company's valuation to its sales, where the value 9.70 reflects the current magnitude. Production is based on strict compliance with RoHS environmental standards for electronics disposal.

ASXC TransEnterix P/S Multiple (07/04/2022 - 08/31/2024)

Analytical breakdowns for Asensus Surgical, Inc. (ASXC)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
General company analysis:ASXC Asensus Surgical Inc
Core merchandise of Asensus Surgical

The P/S multiple determines the market value of one dollar of revenue, allowing for an assessment of the premium paid for an asset relative to its ability to generate cash flow. By analyzing the P/S level of Asensus Surgical, Inc. (ASXC), an investor can see to what extent the market prices in the potential of Asensus Surgical, Inc. (ASXC) to capture the robotic surgery niche and implement AI-assisted systems into hospital practice.

Competitors of Asensus Surgical, Inc.

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corporation)|Price-to-Revenue Ratio Sensus Healthcare Corp|Market Cap to Revenue Zynex Corp (ZYXI)|P/S Multiple ECOR|RBOT - Price to Sales|Price-to-Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Revenue Ratio|IRIX: Market Cap to Revenue|Intelligent Bio Solutions - Market Cap to Sales Volume|XAIR: P/S Multiple|profusa.com (PFSA) - P/S Multiple|Price-to-Revenue Ratio STRATA Skin Sciences Inc.|glucotrack.com (GCTK) - Price-to-Revenue Coefficient|P/S Multiple NAOV|VERO - Price to Sales|Price-to-Revenue Ratio Nuwellis, Inc. NUWE|AEMD: Market Cap to Revenue Ratio|AVGR - Price-to-Revenue Ratio|Price-to-Revenue Coefficient BioSig BSGM|CUTR (Cutera, Inc) - Market Cap to Revenue|Know Labs Corporation (KNW) - P/S Multiple|Price-to-Revenue Ratio Inari Medical, Inc.|nevro.com (NVRO) - Price-to-Revenue Coefficient|Market Cap to Revenue RSLS (ReShape Lifesciences)|SILK (Silk Road Medical, Inc.) - Market Capitalization-to-Revenue Ratio